Christine Fox, Executive Vice President, U.S. Commercial

Christine Fox

Executive Vice President, U.S. Commercial

Christine (Chris) Fox was appointed Executive Vice President, U.S. Commercial on November 20, 2023, leading all commercial activities for Teva in the U.S., including our generics, biosimilars and innovative medicines business.

Chris brings more than 30 years of healthcare industry experience with leadership roles in sales, marketing, and commercial operations, responsible for teams ranging from 2500+ associates to small, nimble consulting teams. She has a deep understanding of issues affecting the pharmaceutical and biotech sectors, as well as expertise across a range of therapy areas.

Prior to Teva, Chris served as President at Novartis Gene Therapies since December 2021. Previously, Chris was vice president and general manager for the Bone, Cardiometabolic and Nephrology business for Amgen. She also served as the general manager of the company’s United Kingdom and Ireland affiliate. Earlier in her career, she also held leadership positions at Merck, Takeda, and several startups.

Richard Francis joined as Chief Executive Officer (CEO) of Teva Pharmaceutical Industries in January 2023

Richard Francis

President and Chief Executive Officer, Member of the Board of Directors

Read more

Vikki Conway

Acting Head of Global Human Resources

Read more

Richard Daniell

Executive Vice President, European Commercial

Read more

Eric Drapé

Executive Vice President, Global Operations

Read more

Angus J. Grant, PhD

Executive Vice President, Business Development

Read more
image of Dr. Eric A. Hughes, Executive Vice President, Global R&D and Chief Medical Officer

Dr. Eric A. Hughes

Executive Vice President, Global R&D and Chief Medical Officer

Read more

Eli Kalif

Executive Vice President, Chief Financial Officer (CFO)

Read more
David McAvoy - Teva Pharmaceuticals Chief Legal Officer

David McAvoy

Executive Vice President, Chief Legal Officer

Read more

Mark Sabag

Executive Vice President, International Markets Commercial

Read more

Nir Baron

Senior Vice President, Chief Internal Auditor

Read more

Kathleen Veit

Senior Vice President, Global Compliance & Ethics Officer

Read more